This Hartford Insurance Group Insider Reduced Their Stake By 34%
Viewing insider transactions for The Hartford Insurance Group, Inc.'s (NYSE:HIG ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in relation to shares purchased.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.
In the last twelve months, the biggest single sale by an insider was when the Executive VP & Chief Risk Officer, Robert Paiano, sold US$1.5m worth of shares at a price of US$111 per share. That means that even when the share price was below the current price of US$116, an insider wanted to cash in some shares. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 34% of Robert Paiano's holding. The only individual insider seller over the last year was Robert Paiano.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
See our latest analysis for Hartford Insurance Group
For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Hartford Insurance Group insiders own 0.3% of the company, currently worth about US$111m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
It doesn't really mean much that no insider has traded Hartford Insurance Group shares in the last quarter. While we feel good about high insider ownership of Hartford Insurance Group, we can't say the same about the selling of shares. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Hartford Insurance Group .
Of course Hartford Insurance Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution
In the last year, many Cardinal Health, Inc. (NYSE:CAH) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The CEO & Director, Jason Hollar, made the biggest insider sale in the last 12 months. That single transaction was for US$8.0m worth of shares at a price of US$109 each. That means that an insider was selling shares at slightly below the current price (US$161). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 46% of Jason Hollar's holding. Cardinal Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! View our latest analysis for Cardinal Health I will like Cardinal Health better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying. Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Cardinal Health insiders own about US$146m worth of shares (which is 0.4% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders. The fact that there have been no Cardinal Health insider transactions recently certainly doesn't bother us. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Cardinal Health insiders selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we found 1 warning sign for Cardinal Health that deserve your attention before buying any shares. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching
Today we're going to take a look at the well-established HCA Healthcare, Inc. (NYSE:HCA). The company's stock saw a decent share price growth of 19% on the NYSE over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine HCA Healthcare's valuation and outlook in more detail to determine if there's still a bargain opportunity. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Good news, investors! HCA Healthcare is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that HCA Healthcare's ratio of 15.45x is below its peer average of 20.5x, which indicates the stock is trading at a lower price compared to the Healthcare industry. Although, there may be another chance to buy again in the future. This is because HCA Healthcare's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity. See our latest analysis for HCA Healthcare Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. HCA Healthcare's earnings over the next few years are expected to increase by 23%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since HCA is currently below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple. Are you a potential investor? If you've been keeping an eye on HCA for a while, now might be the time to make a leap. Its buoyant future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy HCA. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed assessment. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Our analysis shows 3 warning signs for HCA Healthcare (1 is a bit concerning!) and we strongly recommend you look at these before investing. If you are no longer interested in HCA Healthcare, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Miami Herald
30 minutes ago
- Miami Herald
The 10 most popular new cars & SUVs of 2025 (so far), according to Consumer Reports
Looming economic uncertainties, stubbornly high interest rates, and Trump's tariffs on imported auto parts and automobiles might lead you to think that 2025 is the worst time ever to buy a new car. But 3.9 million new vehicles were sold in the first few months of the year, which represented a 4% increase over 2024. And while current economic headwinds have caused Cox Automotive to reduce its full-year new vehicle sales estimates from 16.3 million to 15.6 million, that still means millions of people are heading over to their dealerships to purchase a new car or SUV. Because the simple fact is, if you need a new car, you need a new car. Don't miss the move: Subscribe to TheStreet's free daily newsletter Buying a new vehicle seems to be an increasingly smart investment, due to the fact that used cars aren't the steals they used to be. Their prices have also been on the rise: According to data from Edmunds, the average price of a three-year-old vehicle is now an incredible $30,522, which significantly narrows the cost differential between new and used vehicles. There are plenty of advantages to buying a new vehicle, with safety and reliability at the top of the list. Related: The 10 most reliable car brands in 2025 according to Consumer Reports New cars are safer Due to advancements in safety technologies and structural designs, new cars typically have more standard safety features than used vehicles. These days, automatic emergency braking (AEB) comes standard on most new vehicles, while blind-spot monitoring and rear cross-traffic warning systems are other common new-vehicle features that can often help to prevent accidents from occurring in the first place. New cars are more reliable In addition, shiny new cars come with shiny new components, lessening the chance of immediate mechanical issues. They also have the added benefit of a factory warranty, which covers repairs for a certain period-something older, pre-owned vehicles might not. Consumer Reports (CR), the venerable product testing and consumer advocacy organization, has been in business since 1936, which means it has weathered economic ups and downs for 89 years. In fact, its entire purpose, which is to provide unbiased reviews of tens of thousands of products in order to inform consumers on product quality and safety, was shaped by the harsh economic realities of the Great Depression. Related: The 10 best compact crossover SUVs according to Consumer Reports Acknowledging the challenges car buyers face in 2025, CR put together a few helpful hints for consumers so they can avoid overpaying for their vehicles. They include: Avoid buying first-year "redesigned" models, which have received plenty of media hype and, often, a steep price tag to match. Instead, CR suggests waiting another year so that the vehicles' inflated sticker price comes down-and any "kinks" the new model experiences have been worked out, consumers should select smaller vehicles, or ones with fewer features, simply due to the fact that they have lower material and manufacturing costs. Because smaller vehicles weigh less, they also experience lower destination charges, which get passed on to the consumer. CR suggests that car buyers do their research online and find out what prices cars in their area are selling for, as well as what their MSRP is. That can help you determine a vehicle's true value-as well as how much you're willing to spend to get it. Consumer Reports listens to the feedback it receives from its 6 million members; in fact, it takes into account which cars and SUVs consumers are searching for online when it compiles its list of "most popular" vehicles. More on Consumer Reports: The best gas grills under $250, ranked by Consumer Reports dataThe least expensive car brands to repair & maintain according to Consumer ReportsTop 10 electric cars that aren't Tesla, based on Consumer Reports data But the venerable consumer advocacy group doesn't stop at data. It then cross references these vehicles with results from its own, extensive internal tests in order to rank its list in order of highest-rated vehicles. This helps consumers to know they're making the smartest possible buying decision-no matter what's going on in the world at large. CR road-tests dozens of vehicles at its testing facility in Colchester, Connecticut, putting each car and SUV through a barrage of tests, including acceleration, braking, crash testing, emergency handling, smoothness of ride, and fuel economy, to name a few. It then surveys its members on metrics such as reliability and overall satisfaction, combining all results together into its Overall Score. CR notes that each of the vehicles on its list of "Most Popular New Cars and SUVs" have received high Overall Scores. And, all of these vehicles are categorized as SUVs. However, while all of the vehicles that made its list come with standard automatic emergency braking (AEB), it notes which ones also come with blind-spot monitoring and rear cross-traffic warning systems. Here's the list: 2025 Subaru Forester MPG: Overall 29 / Hwy 39 Price: $29,995–$43,295 2025 Toyota RAV4 MPG: Overall 27 / Hwy 38Price: $29,250–$40,605 2025 Honda CR-V MPG: Overall 26 / Hwy 33Price: $30,100–$50,000 OWS Photography, CC BY 4.0, via Wikimedia Commons 2025 Subaru Crosstrek MPG: Overall 29 / Hwy 41 Price: $26,560–$33,360 2025 Toyota RAV4 Hybrid MPG: Overall 37 / Hwy 41 Price: $28,850–$40,205 Ethan Llamas, CC BY-SA 4.0, via Wikimedia Commons 2025 Mazda CX-5 MPG: Overall 24 / Hwy 33 Price: $28,770–$40,800 2025 Honda CR-V Hybrid MPG: Overall 35 / Hwy 38 Price: $34,650–$41,100 2025 Toyota Highlander MPG: Overall 22 / Hwy 33 Price: $39,820–$53,975 2025 Toyota Highlander Hybrid MPG: Overall 35 / Hwy 41 Price: $39,520–$53,675 Related: 8 popular vehicles that are less reliable than you think, according to Consumer Reports The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
